Table 2.
SYTL4 expression correlated with the levels of immune cell markers in AML.
Markers | Correlation coefficient | P | Markers | Correlation coefficient | P | Markers | Correlation coefficient | P |
---|---|---|---|---|---|---|---|---|
LAG3 | 0.431 | <0.001 | IFNG | 0.165 | 0.043 | HLA-DQB1 | −0.076 | 0.354 |
KIR2DL3 | 0.424 | <0.001 | CCR8 | 0.165 | 0.043 | NOS2 | 0.075 | 0.359 |
KIR2DL4 | 0.413 | <0.001 | STAT5B | 0.157 | 0.054 | BCL6 | −0.069 | 0.397 |
KIR3DL2 | 0.413 | <0.001 | STAT6 | 0.156 | 0.056 | CD163 | 0.068 | 0.409 |
KIR2DL1 | 0.410 | <0.001 | PTGS2 | 0.152 | 0.063 | CD2 | 0.060 | 0.462 |
KIR3DL1 | 0.400 | <0.001 | STAT3 | 0.149 | 0.069 | IRF5 | −0.059 | 0.470 |
GZMB | 0.362 | <0.001 | CSF1R | −0.146 | 0.074 | IL13 | −0.058 | 0.478 |
KIR2DS4 | 0.313 | <0.001 | CD86 | −0.139 | 0.089 | MS4A4A | −0.053 | 0.521 |
TBX21 | 0.313 | <0.001 | CD8B | 0.135 | 0.098 | HLA-DPB1 | 0.053 | 0.519 |
FOXP3 | 0.291 | <0.001 | STAT1 | 0.129 | 0.114 | VSIG4 | −0.048 | 0.558 |
CTLA4 | 0.284 | <0.001 | CD1C | −0.125 | 0.126 | IL17A | −0.046 | 0.577 |
STAT4 | 0.275 | <0.001 | CCR7 | 0.125 | 0.126 | HLA-DPA1 | 0.045 | 0.585 |
GATA3 | 0.275 | <0.001 | ITGAX | 0.120 | 0.143 | IL10 | 0.039 | 0.636 |
CD68 | −0.217 | 0.008 | CD19 | 0.108 | 0.188 | HLA-DQB3 | 0.039 | 0.634 |
STAT5A | 0.216 | 0.008 | HAVCR2 | −0.107 | 0.193 | ITGAM | 0.039 | 0.630 |
CD8A | 0.195 | 0.016 | CD79A | 0.104 | 0.205 | CD3D | 0.023 | 0.778 |
CD3E | 0.189 | 0.020 | IL21 | 0.103 | 0.207 | HLA-DRA | 0.014 | 0.860 |
KIR3DL3 | 0.186 | 0.022 | TNF | −0.097 | 0.235 | HLA-DQB2 | −0.006 | 0.938 |
PDCD1 | 0.183 | 0.025 | CCL2 | 0.095 | 0.245 | CEACAM8 | 0.004 | 0.958 |
NRP1 | −0.181 | 0.026 |
Note: AML, acute myeloid leukemia.